trimetazidine has been researched along with Insulin Resistance in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M | 1 |
| Cheng, J; Dun, Y; Fu, S; Li, C; Liu, S; Qiu, L; Ripley-Gonzalez, JW; You, B; Zhang, W | 1 |
| Fillmore, N; Ilkayeva, OR; Jaswal, JS; Keung, W; Koves, TR; Lopaschuk, DG; Lopaschuk, GD; Mori, J; Muoio, DM; Ussher, JR; Wagg, CS; Zhang, L | 1 |
| Abdel-Kawy, HS; El Serafy, OMH; Hasanin, AH; Hassan, OA; Raafat, MH; Sedky, AA | 1 |
| Camisasca, RP; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Origgi, A; Piatti, P; Setola, E | 1 |
| Cai, JS; Peng, ZJ | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
2 trial(s) available for trimetazidine and Insulin Resistance
| Article | Year |
|---|---|
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Citric Acid; Cross-Over Studies; Cyclic GMP; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Fatty Acids, Nonesterified; Forearm; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Muscle, Skeletal; Myocardial Ischemia; Oxidation-Reduction; Trimetazidine | 2006 |
[Effect of trimitazidine on insulin resistance in patients with coronary heart disease].
Topics: Adult; Blood Glucose; Cohort Studies; Coronary Artery Disease; Female; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |
5 other study(ies) available for trimetazidine and Insulin Resistance
| Article | Year |
|---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism | 2011 |
Trimetazidine and exercise offer analogous improvements to the skeletal muscle insulin resistance of mice through Nrf2 signaling.
Topics: Animals; Humans; Insulin Resistance; Mice; Muscle, Skeletal; NF-E2-Related Factor 2; Signal Transduction; Trimetazidine | 2022 |
Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.
Topics: Acetyl-CoA C-Acyltransferase; Angina Pectoris; Animals; Cells, Cultured; Diet, High-Fat; Fatty Acids; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipid Metabolism; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Myocytes, Cardiac; Obesity; Oxidation-Reduction; Rats; Trimetazidine; Vasodilator Agents | 2014 |
Trimetazidine potentiates the antiepileptic activity and ameliorates the metabolic changes associated with pentylenetetrazole kindling in rats treated with valproic acid.
Topics: Animals; Anticonvulsants; Aorta; Biomarkers; Blood Glucose; Drug Synergism; Epilepsy; Hippocampus; Insulin; Insulin Resistance; Kindling, Neurologic; Liver; Male; Oxidative Stress; Pentylenetetrazole; Rats; Rats, Wistar; Trimetazidine; Valproic Acid | 2017 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |